Quality of life of patients undergoing clean intermittent self-catheterization with hydrophilic-coated catheters is better than that of patients using disposable catheters without hydrophilic coating

Matsuo T1, Ito H1, Kurata H1, Nakanishi H1, Mitsunari K1, Ohba K1, Sakai H2, Miyata Y1

Research Type

Clinical

Abstract Category

Quality of Life / Patient and Caregiver Experiences

Abstract 571
Open Discussion ePosters
Scientific Open Discussion Session 34
Saturday 10th September 2022
13:05 - 13:10 (ePoster Station 6)
Exhibition Hall
Quality of Life (QoL) Voiding Dysfunction Questionnaire
1. Nagasaki University Hospital, 2. Nagasaki Rousai Hospital
Unconfirmed Presentation Method
Presenter
Links

Abstract

Hypothesis / aims of study
Urinary management in patients with lower urinary tract dysfunction such as neurogenic bladder is crucial for preventing urinary tract infections and protecting renal function. While pharmacotherapy can usually address voiding disorders, patients in whom pharmacotherapy is ineffective may undergo clean intermittent self-catheterization (CISC). Although the above issues can be resolved by using CISC to manage urination, the quality of life (QOL) becomes a concern in patients undergoing CISC several times per day.
In clinical settings, CISC is primarily performed using three types of catheters—reusable, uncoated single use, and hydrophilic-coated single use. However, there has been little research on how these three catheter types can affect patients’ QOL. This study aimed to investigate the differences in QOL among patients using the three catheter types for CISC.
Study design, materials and methods
We examined patients undergoing CISC at our institution for lower urinary tract disorders such as neurogenic bladder and prostatic hypertrophy. After fully explaining how each catheter is used, the patients were asked to choose one of the three types. The differences in the QOL between the three groups after one month of catheter use were evaluated using the Japanese version of the Intermittent Self-catheterization Questionnaire (J-ISC-Q) and compared by statistical methods. P<0.05 was considered a statistically significant difference.
Results
There were 93 patients (38 men, 40.9%) in the analysis set, including 35 patients in the reusable group (18 men, 51.4%), 38 in the uncoated group (13 men, 34.2%), and 20 in the coated group (7 men, 35.0%) (P=0.284). The mean age was not significantly different between the three groups, while the coated group had the fewest urethral catheterizations at 3.2±1.9 times per day (P=0.001). While the total J-ISC-Q score did not differ significantly between the groups, the coated group had the highest score (reusable group 54.9±10.1, uncoated group 56.5±16.3, coated group 63.6±13.4, P=0.133).
There were no significant differences between the groups in the subscales for convenience and psychological well-being (convenience score: P=0.110, psychological well-being score: P=0.310). 
However, the coated group had the highest score for ease of use, indicating that catheter use was the easiest in this group (reusable group 67.3±14.9, uncoated group 70.7±18.4, coated group 80.2±7.5, P=0.013), and the best discreetness score (reusable group 49.8±26.0, uncoated group 56.8±24.1, coated group 69.2±15.7, P=0.023).
Interpretation of results
The overall QOL of patients undergoing CISC using hydrophilic-coated catheters did not differ from that of the other two groups, although the catheters were easier to use and more discreet in the coated group. Although coated urinary catheters have been reported to reduce the risk of urinary tract infections compared to other catheter types, our results suggest they may also be useful in ensuring a better QOL while undergoing urethral catheterization and maintaining CISC adherence.
Concluding message
Among the patients undergoing CISC, those using a catheter with a hydrophilic coating are considered to be able to maintain the best QOL.
Disclosures
Funding None. Clinical Trial No Subjects Human Ethics Committee Ethics Committee of Nagasaki University Hospital Helsinki Yes Informed Consent Yes
13/12/2024 15:30:36